SEC Form 4 · accession 0001209191-15-035508
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mitchell H. Finer
Officer — Chief Scientific Officer
Period of report
Apr 20, 2015
Accepted (ET)
Apr 22, 2015 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 20, 2015 | M | 1,166 | $2.0864 | A | 1,166 | D | |
| Common Stock | Apr 20, 2015 | M | 13,834 | $5.5004 | A | 15,000 | D | |
| Common StockF2 | Apr 20, 2015 | S | 2,520 | $123.5253 | D | 12,480 | D | |
| Common StockF3 | Apr 20, 2015 | S | 1,689 | $124.706 | D | 10,791 | D | |
| Common StockF4 | Apr 20, 2015 | S | 5,457 | $125.6223 | D | 5,334 | D | |
| Common StockF5 | Apr 20, 2015 | S | 750 | $126.6818 | D | 4,584 | D | |
| Common StockF6 | Apr 20, 2015 | S | 3,875 | $127.8359 | D | 709 | D | |
| Common Stock | Apr 20, 2015 | S | 11 | $128.25 | D | 698 | D | |
| Common StockF7 | Apr 20, 2015 | S | 628 | $130.5741 | D | 70 | D | |
| Common StockF8 | Apr 20, 2015 | S | 70 | $131.29 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F9 | $2.0864 | Apr 20, 2015 | M | 900 | D | — | Jul 13, 2021 | Common Stock | 900 | 0 | D |
| Stock Option (right to buy)F9 | $2.0864 | Apr 20, 2015 | M | 266 | D | — | Jul 13, 2021 | Common Stock | 266 | 0 | D |
| Stock Option (right to buy)F10 | $5.5004 | Apr 20, 2015 | M | 8,384 | D | — | Jan 16, 2023 | Common Stock | 8,384 | 30,371 | D |
| Stock Option (right to buy)F11 | $5.5004 | Apr 20, 2015 | M | 5,450 | D | — | Jan 16, 2023 | Common Stock | 5,450 | 114,364 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2014.
- F10This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.
- F11This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of May 1, 2013. The shares underlying these options vested as follows: 25% vested on May 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.
- F2The range of prices for the transaction reported on this line was $123.14 to $124.08. The average weighted price was $123.5253. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $124.15 to $125.10. The average weighted price was $124.7060. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $125.21 to $126.18. The average weighted price was $125.6223. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range of prices for the transaction reported on this line was $126.23 to $126.92. The average weighted price was $126.6818. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range of prices for the transaction reported on this line was $127.2350 to $128.20. The average weighted price was $127.8359. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range of prices for the transaction reported on this line was $130.00 to $131.00. The average weighted price was $130.5741. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8The range of prices for the transaction reported on this line was $131.25 to $131.35. The average weighted price was $131.29. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F9This option vests at a rate of twenty-five percent (25%) on April 15, 2012 and in 36 equal monthly installments thereafter.